Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

Investigating the zoonotic adaptation and anthropozoonotic transmission of SARS-CoV-2

Researchers summarize the possible causes and routes of transmission of SARS-CoV-2 between humans and animals.

2 Dec 2021

Study explores the emergence and spread of SARS-CoV-2 Delta variant across Brazil

Brazilian researchers aim to determine the emergence and spread of the Delta VOC in different regions in Brazil.

2 Dec 2021

Hospitals refused to give patients ivermectin. Lockdowns and political pressure followed.

One Montana hospital went into lockdown and called police after a woman threatened violence because her relative was denied her request to be treated with ivermectin.

2 Dec 2021

As climate worsens, environmentalists grapple with the mental toll of activism

While growing up in the ’90s in Johnson County, Kansas, in a suburb of Kansas City, I had a friend, Kevin Aaron, who was a dedicated environmentalist.

2 Dec 2021

New insights offered into cell-to-cell propagation of SARS-CoV-2

Evidence from a new study supports previous findings showing SARS-CoV-2 particles inside host cells are morphologically identical to those outside of cells.

2 Dec 2021

Systematic survey of human SARS-CoV-2 monoclonal antibodies

Scientists have mined information from several research publications and patents to create a dataset of approximately 8000 human antibodies to the SARS-CoV-2 spike from more than 200 donors.

2 Dec 2021

Study suggests efficacy of SARS-CoV-2 main protease inhibitors is not compromised in current COVID-19 variants

A new study has focussed on assessing the Mpro mutants of newly emerged SARS-CoV-2 variants.

2 Dec 2021

Preventing SARS-CoV-2 transmission at large indoor events

A new trial showed that indoor live events are not associated with an increased risk of SARS-CoV-2 infection, provided preventive interventions are in place.

2 Dec 2021

Natural triterpenoids in licorice found to inhibit SARS-CoV-2

In new studies, researchers concluded that licorice triterpenoids could be candidates for anti-SARS-CoV-2 drug developments.

2 Dec 2021

Pandemic lockdown created mental and emotional issues for older adults with sensory impairment

During the first year of the COVID-19 pandemic, many assisted living and senior center facilities were forced to close their doors to outside visitors to limit potential exposure to the virus.

1 Dec 2021

Pandemic may have impaired people's cognitive abilities and altered risk perception

The COVID-19 pandemic has tested our psychological limits. Some have been more affected than others by the stress of potential illness and the confusion of constantly changing health information and new restrictions.

1 Dec 2021

New assessment finds 40% of the adults to be obese or overweight

The fight against obesity and undernourishment stalled during the COVID-19 pandemic, with over 40 per cent of adults now obese or overweight, the world's leading independent assessment of the state of global nutrition has found.

1 Dec 2021

SARS-CoV-2 transmission across age groups makes age-based interventions ineffective

Researchers review critically evaluated the transmission dynamics of SARS-CoV-2 across various ages in metropolitan France.

1 Dec 2021

New NCCN patient guideline explains when and how to screen for colorectal cancer

The National Comprehensive Cancer Network today announced the publication of new NCCN Guidelines for Patients: Colorectal Cancer Screening.

1 Dec 2021

Impact of engineered ACE2-Fc on SARS-CoV-2 infection

Researchers employ a structure-guided approach for the development of a series of ACE2-Fc variants using human IgG1 or IgG3 backbone.

1 Dec 2021

Novel approach to estimate transmission advantage of SARS-CoV-2 variants in real-time

A new study retrospectively estimates the effective transmission advantage of the Alpha variant as compared to other non-VOC lineages.

1 Dec 2021

Longer interval between COVID-19 mRNA vaccine doses leads to stronger immune response

The first peer-reviewed study in North America examining the timing between the first and second doses of COVID-19 mRNA vaccines shows that a longer dose interval leads to a stronger immune response. The study is funded by the Government of Canada through its COVID-19 Immunity Task Force.

1 Dec 2021

COVID-19 pandemic has a long-lasting impact on the future of nursing, survey reveals

Cross Country Healthcare, Inc., a leading provider of advisory and workforce solutions, including contingent staffing, permanent placement and other consultative services for healthcare clients, today announced the results from a nationally represented survey of nurses and nursing students showing that the COVID-19 pandemic has introduced long-lasting negative perceptions of their future careers.

1 Dec 2021

Impact of partial lockdown on breaking COVID-19 fourth wave in Bavaria

An agent-based simulator was used to determine the historical course of COVID-19 and to analyze the effectiveness of lockdown.

1 Dec 2021

Structure function analysis of potent antibodies against Beta SARS-CoV-2 variant

A team of researchers from UK and US institutions created a large panel of mAbs derived from memory B cells of convalescent Beta subjects to better understand the antigenic landscape of Beta.

1 Dec 2021

Pandemic News and Research

Further Reading

Investigating the zoonotic adaptation and anthropozoonotic transmission of SARS-CoV-2

Study explores the emergence and spread of SARS-CoV-2 Delta variant across Brazil

Hospitals refused to give patients ivermectin. Lockdowns and political pressure followed.

As climate worsens, environmentalists grapple with the mental toll of activism

New insights offered into cell-to-cell propagation of SARS-CoV-2

Systematic survey of human SARS-CoV-2 monoclonal antibodies

Study suggests efficacy of SARS-CoV-2 main protease inhibitors is not compromised in current COVID-19 variants

Preventing SARS-CoV-2 transmission at large indoor events

Natural triterpenoids in licorice found to inhibit SARS-CoV-2

Pandemic lockdown created mental and emotional issues for older adults with sensory impairment

Pandemic may have impaired people's cognitive abilities and altered risk perception

New assessment finds 40% of the adults to be obese or overweight

SARS-CoV-2 transmission across age groups makes age-based interventions ineffective

New NCCN patient guideline explains when and how to screen for colorectal cancer

Impact of engineered ACE2-Fc on SARS-CoV-2 infection

Novel approach to estimate transmission advantage of SARS-CoV-2 variants in real-time

Longer interval between COVID-19 mRNA vaccine doses leads to stronger immune response

COVID-19 pandemic has a long-lasting impact on the future of nursing, survey reveals

Impact of partial lockdown on breaking COVID-19 fourth wave in Bavaria

Structure function analysis of potent antibodies against Beta SARS-CoV-2 variant

Best practices - optimize qPCR processes for pathogen detection eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News